Analog DevicesADN4620BRSZDigital Isolators
Digital Isolator Logic 2-CH 2.5Gbps 20-Pin SSOP Tube
ADN4620 Family: 3.75 kV rms, Dual LVDS 2.5 Gigabit Isolators
The ADN4620 family of gigabit isolators protect gigabit bandwidth AFEs from EMC transients with Analog Devices' trusted safety and data integrity. This product meets safety requirements for CAT II 1000V rms, even with high measurement channel density.
- • ADN4620: 3.75 kV rms Dual LVDS 2 Gbps Isolator (0 Reverse Channels)
- • ADN4621: 3.75 kV rms Dual LVDS 2 Gbps Isolator (1 Reverse Channels)
Key Features and Benefits:
- • 5 Gbps total bandwidth through 2-channel isolator offers short-reach fiber replacement
- • <1 ps ultralow jitter and <40 ps skew for precise timing and accurate measurement/isolation of ADC converter clocks
- • LVDS compliant inputs and outputs as a drop-in solution minimizes design time
Applications:
- • Instrumentation and Measurement: Data acquisition, source meter, data logger, oscilloscope, automatic test, optical inspection, image sensor
- • Aerospace and Defense: Drones, radar, imaging, UAV, avionics, display unit, cockpit
- • Industrial Automation: Robots, cobots, drives, PLC, backplane, PCI express, relays, power supply
- • Automotive: Autonomous vehicle, infotainment, cabin, automotive test, inverters
The ADN4620 can be evaluated with the EVAL-ADN4620EBZ
Block Diagrams and Tables:



| Compliant | |
| EAR99 | |
| Active | |
| 8542.39.00.90 | |
| Automotive | No |
| PPAP | No |
| General Purpose | |
| 2 | |
| 2.5Gbps(Min) | |
| 0.18 | |
| 0.18 | |
| Logic | |
| 1.9 | |
| 1.7 | |
| 2.8 | |
| 3750 | |
| 2.8 | |
| 1500Vp | |
| 1890 | |
| -40 | |
| 125 | |
| Tube | |
| 1.8 | |
| 2/0 | |
| 35 | |
| Magnetic Coupling | |
| Mounting | Surface Mount |
| Package Height | 1.75 mm |
| Package Width | 5.3 mm |
| Package Length | 7.2 mm |
| PCB changed | 20 |
| Standard Package Name | SO |
| Supplier Package | SSOP |
| 20 | |
| Lead Shape | Gull-wing |
| EDA / CAD Models |
Design AI-powered medical devices
Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.

